aHUS Clinical Trial
Official title:
A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in Atypical Hemolytic Uremic Syndrome (aHUS) Patients in South Korea
Primary objective - To determine the clinical prognosis by identifying the disease course and severity by treatment with or without eculizumab in patients with aHUS in Korea. Secondary objectives - To determine the clinical prognosis of the disease in all patients with aHUS in Korea. - To determine the clinical prognosis of the disease in patients diagnosed with aHUS prior to the initiation of eculizumab reimbursement system in Korea. - To determine the treatment responses by treatment options in patients with aHUS in Korea. - To identify risk factors that affect mortality in all patients with aHUS in Korea. - To investigate the recurrence and clinical prognosis in patients with aHUS in Korea when eculizumab is discontinued
As a retrospective, non-interventional, multi-center study ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04725812 -
Complement Regulation to Undo Systemic Harm in Preeclampsia
|
Phase 2 | |
| Completed |
NCT04749810 -
Observational Study of Elizaria® in aHUS Patients
|